Every edition. An expanding view of orthopaedic evidence.
Compression bandaging and soft braces are commonly recommended or self-applied for knee osteoarthritis pain, and this trial suggests short courses of simple elastic compression have no clinically meaningful benefit over a sham wrap or no treatment, which should temper enthusiasm for this low-cost adjunct.
Patients with RA on biologics or JAK inhibitors often come to orthopaedic surgery, and knowing that carefully supervised dose reduction usually preserves disease control helps in perioperative medication discussions and co-management with rheumatology.
Psoriatic arthritis can cause erosive hand and foot joint destruction that orthopaedic surgeons may later reconstruct, so knowing which biologics slow radiographic damage helps with referral and with counselling before surgery.
Duloxetine is a guideline-listed option for osteoarthritis pain, and students should know that its benefit is small, best shown against placebo, and comes with more side effects.
Denosumab discontinuation can trigger multiple vertebral fractures, so knowing to plan a bisphosphonate transition (often zoledronic acid) is directly relevant to fragility fracture care and exam questions on osteoporosis management.
As AI tools and telehealth enter musculoskeletal care, this suggests patients may trust clinicians less when AI use is visible, which matters for how clinicians communicate about technology.
Musculoskeletal trainees who see psoriatic arthritis patients should know that response to advanced therapy is often incomplete, and that baseline pain burden, obesity and disease severity predict poorer persistence.
It suggests that hopes for a synovial biochemical biomarker to substitute for or supplement radiographic/clinical staging of knee osteoarthritis are not yet supported, reinforcing that clinical scores remain the practical tool for assessing severity.
It shows that observational links between walking and bone health are modest, may depend on menopausal status, and do not replace resistance or high-impact exercise for postmenopausal osteoporosis prevention.
Patients on biologics or JAK inhibitors commonly ask whether to pause treatment around vaccination, and this trial suggests pausing adds flare risk without a measurable antibody gain.
JAK inhibitors are a common next step in refractory RA, and real-world persistence data help clinicians choose among agents, especially after prior IL-6 or JAK inhibitor failure.
Orthopaedic surgeons increasingly encounter AI-assisted imaging tools, and this review shows the evidence supporting their clinical use remains extremely thin despite hype.
Anemic MI patients are common in both cardiology and perioperative orthopaedic settings, and this reanalysis illustrates how a 'negative' P=.07 trial can be reframed as supportive evidence using Bayesian statistics, a distinction trainees should recognise when reading transfusion literature.
